Graduated from Zhejiang University, School of Medicine in 2010 with a M.D. in Oncology. Served as a medical oncologist for 10 years in the First Affiliated Hospital of Zhejiang University School of Medicine. Expertise in chemotherapy, targeting therapy and immunotherapy for cancer, especially in GI cancers (hepatobiliary and pancreatic cancers / gastric cancer / colorectal cancer, etc.). As Sub-I, responsible for a number of clinical trials of new targeting and immunotherapy drugs for hepatobiliary and pancreatic malignancies.

Main research interest is the impact of gut microbiome on the efficacy of cancer immunotherapy. Published more than 10 articles indexed by SCI, including two papers IF> 5.0. Also co-authored in one book (People's Medical Publishing House), and participated in the composition of Chinese Society of Clinical Oncology Biliary Tract Cancer Expert Consensus.

Hepatobiliary and pancreatic cancers

Gastric cancer / esophageal cancer / colorectal cancer

Cancer immunotherapy, including CAR-T therapy for solid tumor

Gut microbiome

Visiting scholar of Brown University, United States

Visiting scholar of Azienda Sanitaria di Firenze (ASF), Italy

Member of Chinese Society of Clinical Oncology (CSCO), HCC committee

Secretary of Chinese Society of Clinical Oncology (CSCO), BTC committee